School of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Bioprocess Engineering, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.
Braz J Med Biol Res. 2024 Aug 23;57:e13889. doi: 10.1590/1414-431X2024e13889. eCollection 2024.
With the escalating incidence and mortality rates of cancer, there is an ever-growing emphasis on the research of anticancer drugs. Cordycepin, the primary nucleoside antibiotic isolated from Cordyceps militaris, has emerged as a remarkable agent for cancer prevention and treatment. Functioning as a natural targeted antitumor drug, cordycepin assumes an increasingly pivotal role in cancer therapy. This review elucidates the mechanisms of cordycepin in inhibiting tumor cell proliferation, inducing apoptosis, as well as its capabilities in suppressing angiogenesis and metastasis. Moreover, the immunomodulatory effects of cordycepin in cancer treatment are explored. Additionally, the current status, challenges, and future prospects of cordycepin application in clinical trials are briefly discussed. The objective is to provide a valuable reference for the utilization of cordycepin in cancer treatment.
随着癌症发病率和死亡率的不断上升,对抗癌药物的研究越来越受到重视。蛹虫草中分离得到的主要核苷类抗生素虫草素,作为一种具有显著抗癌作用的药物,在癌症治疗中发挥着越来越重要的作用。作为一种天然靶向抗肿瘤药物,虫草素在抑制肿瘤细胞增殖、诱导细胞凋亡、抑制血管生成和转移等方面具有重要作用。此外,还探讨了虫草素在癌症治疗中的免疫调节作用。本文还简要讨论了虫草素在临床试验中的应用现状、挑战和未来前景。旨在为虫草素在癌症治疗中的应用提供有价值的参考。